Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune boosting by B.1.1.529
(
Omicron) depends on previous SARS-CoV-2 exposure
Authors
Keywords
-
Journal
SCIENCE
Volume 377, Issue 6603, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-06-14
DOI
10.1126/science.abq1841
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T-cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
- (2022) Vivek Naranbhai et al. CELL
- SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
- (2022) Alison Tarke et al. CELL
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
- (2022) Kenrie P. Y. Hui et al. NATURE
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
- (2022) Jinyan Liu et al. NATURE
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
- (2022) Lihong Liu et al. NATURE
- Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
- (2022) Yu Gao et al. NATURE MEDICINE
- Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
- (2022) Hung Fu Tseng et al. NATURE MEDICINE
- Population Immunity and Covid-19 Severity with Omicron Variant in South Africa
- (2022) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid increase in Omicron infections in England during December 2021: REACT-1 study
- (2022) Paul Elliott et al. SCIENCE
- Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
- (2022) Catherine J. Reynolds et al. SCIENCE
- Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
- (2022) Alexander Muik et al. SCIENCE
- Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
- (2022) Rishi R. Goel et al. CELL
- mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
- (2022) Matthew Gagne et al. CELL
- SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
- (2022) Simone I. Richardson et al. Cell Host & Microbe
- T cell responses to SARS-CoV-2 spike cross-recognize Omicron
- (2022) Roanne Keeton et al. NATURE
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
- (2022) Annika Rössler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
- (2021) Catherine J. Reynolds et al. Science Immunology
- Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite
- (2021) Gabriele Cerutti et al. Cell Host & Microbe
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
- (2021) Charlotte Manisty et al. LANCET
- Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
- (2021) Charlotte Manisty et al. EBioMedicine
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
- (2021) Matthew McCallum et al. CELL
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
- (2021) Catherine J. Reynolds et al. SCIENCE
- Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells
- (2021) Robert Parker et al. Cell Reports
- Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
- (2021) Benjamin Israelow et al. Science Immunology
- Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
- (2021) Salim S Abdool Karim et al. LANCET
- Beyond Omicron: what’s next for COVID’s viral evolution
- (2021) Ewen Callaway NATURE
- Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
- (2021) Shirley Collie et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19: PCR screening of asymptomatic health-care workers at London hospital
- (2020) Thomas A Treibel et al. LANCET
- NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
- (2020) Birkir Reynisson et al. NUCLEIC ACIDS RESEARCH
- The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
- (2020) Michael D. Knierman et al. Cell Reports
- Chronic Infection by MucoidPseudomonas aeruginosaAssociated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F
- (2015) Kathryn J. Quigley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- T Cell Immunity to the Alkyl Hydroperoxide Reductase ofBurkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis
- (2015) Catherine Reynolds et al. JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search